200 related articles for article (PubMed ID: 34384755)
21. Exploring the mechanism of Cremastra Appendiculata (SUANPANQI) against breast cancer by network pharmacology and molecular docking.
Zhang L; Yang K; Wang M; Zeng L; Sun E; Zhang F; Cao Z; Zhang X; Zhang H; Guo Z
Comput Biol Chem; 2021 Oct; 94():107396. PubMed ID: 33750656
[TBL] [Abstract][Full Text] [Related]
22. Identification of formononetin as the active compound of CR-SR in hepatocellular carcinoma treatment: An integrated approach combining network pharmacology and weighted gene co-expression networks.
Li C; Xie Y; Hu S; Yu H; Xu Y; Shen H; Yuan Y; Gu L; Pu B
Chem Biol Drug Des; 2024 Jan; 103(1):e14363. PubMed ID: 37793997
[TBL] [Abstract][Full Text] [Related]
23. A network pharmacology-based investigation on the bioactive ingredients and molecular mechanisms of Gelsemium elegans Benth against colorectal cancer.
Que W; Chen M; Yang L; Zhang B; Zhao Z; Liu M; Cheng Y; Qiu H
BMC Complement Med Ther; 2021 Mar; 21(1):99. PubMed ID: 33743701
[TBL] [Abstract][Full Text] [Related]
24. A network pharmacology approach to explore active compounds and pharmacological mechanisms of a patented Chinese herbal medicine in the treatment of endometriosis.
Wu Y; Zhu Y; Xie N; Wang H; Wang F; Zhou J; Qu F
PLoS One; 2022; 17(2):e0263614. PubMed ID: 35130311
[TBL] [Abstract][Full Text] [Related]
25. Exploring the mechanisms underlying the therapeutic effect of the
Qing L; Pan B; He Y; Liu Y; Zhao M; Niu B; Gao X
Aging (Albany NY); 2022 Nov; 14(22):9103-9127. PubMed ID: 36403263
[TBL] [Abstract][Full Text] [Related]
26. A metabolic data-driven systems pharmacology strategy for decoding and validating the mechanism of Compound Kushen Injection against HCC.
Wang KX; Chen YP; Lu AP; Du GH; Qin XM; Guan DG; Gao L
J Ethnopharmacol; 2021 Jun; 274():114043. PubMed ID: 33753143
[TBL] [Abstract][Full Text] [Related]
27. Network Pharmacology-Based Study on the Molecular Biological Mechanism of Action for Compound Kushen Injection in Anti-Cancer Effect.
He R; Ou S; Chen S; Ding S
Med Sci Monit; 2020 Jan; 26():e918520. PubMed ID: 31892693
[TBL] [Abstract][Full Text] [Related]
28. An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verification.
Lu S; Meng Z; Tan Y; Wu C; Huang Z; Huang J; Fu C; Stalin A; Guo S; Liu X; You L; Li X; Zhang J; Zhou W; Zhang X; Wang M; Wu J
BMC Complement Med Ther; 2022 Mar; 22(1):54. PubMed ID: 35236335
[TBL] [Abstract][Full Text] [Related]
29. In Silico Network Analysis of Ingredients of Cornus officinalis in Osteoporosis.
Huang F; Guo H; Wei Y; Zhao X; Chen Y; Lin Z; Zhou Y; Sun P
Med Sci Monit; 2021 Apr; 27():e929219. PubMed ID: 33795629
[TBL] [Abstract][Full Text] [Related]
30. Huanglian decoction suppresses the growth of hepatocellular carcinoma cells by reducing
Li M; Shang H; Wang T; Yang SQ; Li L
World J Gastroenterol; 2021 Mar; 27(10):939-958. PubMed ID: 33776365
[TBL] [Abstract][Full Text] [Related]
31. Investigating the molecular mechanism of Qizhu anticancer prescription in inhibiting hepatocellular carcinoma based on high-resolution mass spectrometry and network pharmacology.
Sun J; Ma M; Zhong X; Li J; Yi J; Zhang R; Liu X; Peng L; Sun X; Feng W; Hu R; Huang Q; Lv M; Fan K; Zhou X
J Ethnopharmacol; 2024 Jun; 328():117985. PubMed ID: 38417600
[TBL] [Abstract][Full Text] [Related]
32. Chemoprevention against hepatocellular carcinoma of Cornus officinalis in vitro.
Chang JS; Chiang LC; Hsu FF; Lin CC
Am J Chin Med; 2004; 32(5):717-25. PubMed ID: 15633807
[TBL] [Abstract][Full Text] [Related]
33. Network Pharmacology-Based Strategy to Investigate the Mechanisms of Lenvatinib in the Treatment of Hepatocellular Carcinoma.
Liu P; Han B; Zhang Y; Wang X
Comput Intell Neurosci; 2022; 2022():7102500. PubMed ID: 35720901
[TBL] [Abstract][Full Text] [Related]
34. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
[No Abstract] [Full Text] [Related]
35. In silico and network pharmacology analysis of fucosterol: a potent anticancer bioactive compound against HCC.
Singh K; Kumar P; Singh AK; Singh N; Singh S; Tiwari KN; Agrawal S; Das R; Singh A; Ram B; Tripathi AK; Mishra SK
Med Oncol; 2024 Apr; 41(6):130. PubMed ID: 38676780
[TBL] [Abstract][Full Text] [Related]
36. Marantodes pumilum: Systematic computational approach to identify their therapeutic potential and effectiveness.
Azfaralariff A; Farahfaiqah F; Shahid M; Sanusi SA; Law D; Mohd Isa AR; Muhamad M; Tsui TT; Fazry S
J Ethnopharmacol; 2022 Jan; 283():114751. PubMed ID: 34662662
[TBL] [Abstract][Full Text] [Related]
37. Integrated System Pharmacology Approaches to Elucidate Multi-Target Mechanism of
Khalid HR; Aamir M; Tabassum S; Alghamdi YS; Alzamami A; Ashfaq UA
Molecules; 2022 Sep; 27(19):. PubMed ID: 36234758
[TBL] [Abstract][Full Text] [Related]
38. Identifying cancer-related molecular targets of Nandina domestica Thunb. by network pharmacology-based analysis in combination with chemical profiling and molecular docking studies.
Taha KF; Khalil M; Abubakr MS; Shawky E
J Ethnopharmacol; 2020 Mar; 249():112413. PubMed ID: 31760157
[TBL] [Abstract][Full Text] [Related]
39. Uncovering the anticancer mechanism of Compound Kushen Injection against HCC by integrating quantitative analysis, network analysis and experimental validation.
Gao L; Wang KX; Zhou YZ; Fang JS; Qin XM; Du GH
Sci Rep; 2018 Jan; 8(1):624. PubMed ID: 29330507
[TBL] [Abstract][Full Text] [Related]
40. Microarray Data Mining and Preliminary Bioinformatics Analysis of Hepatitis D Virus-Associated Hepatocellular Carcinoma.
Yu Z; Ma X; Zhang W; Chang X; An L; Niu M; Chen Y; Sun C; Yang Y
Biomed Res Int; 2021; 2021():1093702. PubMed ID: 33564675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]